Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IOP Control After Bevacizumab Injection
NCT00804921Phase 2Completed
- Sponsor
- Universidade de São Paulo
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of acetazolamide and brimonidine in ocular hypertension (4 arms), sponsored by Universidade de São Paulo. Primary endpoint: Intra-ocular pressure variation at 30 months. Status: completed.
02
Drugs
acetazolamidebrimonidine
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT00804921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00804921.